New pill could slow Alzheimer's: major trial underway
Disease control
Ongoing
This study tests a new medicine called AR1001 in people with early Alzheimer's disease. About 1,535 participants will take either the drug or a placebo for 52 weeks to see if it slows memory and thinking decline. The goal is to control the disease, not cure it, and researchers wi…
Phase: PHASE3 • Sponsor: AriBio Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC